We are live on ! Find out more
MCM

M28 Capital Management Portfolio holdings

AUM $47.2M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
+32.33%
1 Year Est. Return
+32.31%
3 Year Est. Return
+200.03%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$102M
AUM Growth
+$10.9M
Cap. Flow
-$6.25M
Cap. Flow %
-6.14%
Top 10 Hldgs %
98.76%
Holding
11
New
–
Increased
1
Reduced
1
Closed
–
Avg Time Held
10 quarters
Top 10 Avg Time Held
8.4 quarters
Top 20 Avg Time Held
10 quarters

Top Buys

Rank Stock Value
1
CRIS icon
Curis
CRIS
+$425K

Top Sells

Rank Stock Value
1
WVE icon
Wave Life Sciences
WVE
+$6.67M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
WVE icon
1
Wave Life Sciences
WVE
$682M
$70.1M 68.79%
5,664,548
-500,000
-8% -$6.67M
2021 Q4
12 quarters
TGTX icon
2
TG Therapeutics
TGTX
$8.48B
$4.86M 4.78%
161,600
– –
2021 Q4
12 quarters
RCKT icon
3
Rocket Pharmaceuticals
RCKT
$281M
$4.85M 4.76%
385,680
– –
2021 Q4
12 quarters
IVVD icon
4
Invivyd
IVVD
$213M
$4.1M 4.02%
9,248,250
– –
2021 Q4
12 quarters
SWTX icon
5
DELISTED
SpringWorks Therapeutics
SWTX
$3.99M 3.92%
110,400
– –
2022 Q4
8 quarters
GUTS icon
6
Fractyl Health
GUTS
$58.6M
$3.82M 3.75%
154,676
– –
2024 Q1
3 quarters
BBIO icon
7
BridgeBio Pharma
BBIO
$12.8B
$3.33M 3.27%
121,200
– –
2021 Q4
12 quarters
PRQR icon
8
ProQR Therapeutics
PRQR
$230M
$2.7M 2.65%
1,019,498
– –
2022 Q1
11 quarters
CRIS icon
9
Curis
CRIS
$1.63M
$1.59M 1.57%
26,053
+4,955
+23% +$425K
2021 Q4
12 quarters
SLN icon
10
Silence Therapeutics
SLN
$613M
$1.27M 1.25%
185,100
– –
2022 Q4
8 quarters
ARWR icon
11
Arrowhead Research
ARWR
$8.86B
$1.27M 1.24%
67,400
– –
2022 Q4
8 quarters

Similar funds

OGC
One68 Global Capital New York $47.2M AUM 6.52% 1-Year Est. Return
BJB
Broadhurst Jeffrey B $47M AUM
JCM
JAT Capital Management Greenwich, Connecticut $47.4M AUM 177.04% 1-Year Est. Return
FDG
Financial Discovery Group Atlanta, Georgia $46.9M AUM
BAM
BTS Asset Management Lincoln, Massachusetts $47.4M AUM 1.28% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
NPCM
New Paradigm Capital Management Great Falls, Virginia $46.8M AUM
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return

M28 Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, M28 Capital Management held 11 positions worth $102M, up 12% from $91M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

M28 Capital Management withdrew a net $6.25M in Q4 2024, reducing 1 holding. Its largest reduction was Wave Life Sciences, cutting an estimated $6.67M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, M28 Capital Management added an estimated $425K to Curis.

  • M28 Capital Management added most to Curis in Q4 2024, an estimated $425K increase.
  • M28 Capital Management's biggest Q4 2024 reduction was Wave Life Sciences, cutting an estimated $6.67M.
  • M28 Capital Management's ten largest holdings make up 99% of its $102M portfolio in Q4 2024.
  • M28 Capital Management opened 0 new positions and closed 0 in Q4 2024.
  • M28 Capital Management's portfolio value rose 12% quarter-over-quarter to $102M.

Based on M28 Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.